03.04.24
Clinical Skin has announced the acquisition of Glytone skincare brand from Pierre Fabre Laboratories. This acquisition enhances Clinical Skin’s product portfolio and expands its presence in the skincare and cosmeceutical skincare industry. Financial terms were not disclosed.
Glytone is known for providing dermatological skincare solutions. The brand has benefitted from Pierre Fabre Laboratories’ dermo-cosmetic solutions for 20 years. Glytone products are formulated to address various dermatological concerns including hyperpigmentation, skin aging and acne.
The brand has a strong customer base with trusted dermatologists in the United States.
Clinical Skin CEO, Jamie Castle commented, "This acquisition aligns perfectly with our mission to continue to scale our offering of skincare solutions that are firmly backed by science and innovation. Glytone's commitment to quality and efficacy complements our own values, and we are excited to work together to further elevate our product offerings."
"We are proud of the legacy we have built at Glytone over the past 2 decades and are confident that joining Clinical Skin’s portfolio will allow the brand to reach new heights," said Lisa Morris, CEO of Pierre Fabre USA." Hand in hand with Clinical Skin, we will now focus on assuring on a smooth transition of the brand to the benefit of patients and dermatologists alike."
See our current list of mergers and acquisitions for 2024.
Glytone is known for providing dermatological skincare solutions. The brand has benefitted from Pierre Fabre Laboratories’ dermo-cosmetic solutions for 20 years. Glytone products are formulated to address various dermatological concerns including hyperpigmentation, skin aging and acne.
The brand has a strong customer base with trusted dermatologists in the United States.
Clinical Skin CEO, Jamie Castle commented, "This acquisition aligns perfectly with our mission to continue to scale our offering of skincare solutions that are firmly backed by science and innovation. Glytone's commitment to quality and efficacy complements our own values, and we are excited to work together to further elevate our product offerings."
"We are proud of the legacy we have built at Glytone over the past 2 decades and are confident that joining Clinical Skin’s portfolio will allow the brand to reach new heights," said Lisa Morris, CEO of Pierre Fabre USA." Hand in hand with Clinical Skin, we will now focus on assuring on a smooth transition of the brand to the benefit of patients and dermatologists alike."
Related News
Last week Bridgepoint finalized its acquisition of RoC skincare from Gryphon Investors.See our current list of mergers and acquisitions for 2024.